- Home
- AMLX vs HFRO Comparison
AMLX vs HFRO Comparison
Compare AMLX & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- HFRO
- Stock Information
- Founded
- AMLX 2014
- HFRO 2000
- Country
- AMLX United States
- HFRO United States
- Employees
- AMLX N/A
- HFRO N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- HFRO Finance/Investors Services
- Sector
- AMLX Health Care
- HFRO Finance
- Exchange
- AMLX Nasdaq
- HFRO Nasdaq
- Market Cap
- AMLX 749.9M
- HFRO 340.3M
- IPO Year
- AMLX 2022
- HFRO N/A
- Fundamental
- Price
- AMLX $12.45
- HFRO $6.60
- Analyst Decision
- AMLX Strong Buy
- HFRO
- Analyst Count
- AMLX 7
- HFRO 0
- Target Price
- AMLX $14.86
- HFRO N/A
- AVG Volume (30 Days)
- AMLX 1.9M
- HFRO 179.8K
- Earning Date
- AMLX 11-06-2025
- HFRO 01-01-0001
- Dividend Yield
- AMLX N/A
- HFRO 8.87%
- EPS Growth
- AMLX N/A
- HFRO N/A
- EPS
- AMLX N/A
- HFRO N/A
- Revenue
- AMLX N/A
- HFRO N/A
- Revenue This Year
- AMLX N/A
- HFRO N/A
- Revenue Next Year
- AMLX N/A
- HFRO N/A
- P/E Ratio
- AMLX N/A
- HFRO N/A
- Revenue Growth
- AMLX N/A
- HFRO N/A
- 52 Week Low
- AMLX $2.59
- HFRO $4.24
- 52 Week High
- AMLX $12.25
- HFRO $6.45
- Technical
- Relative Strength Index (RSI)
- AMLX 80.50
- HFRO 55.33
- Support Level
- AMLX $11.42
- HFRO $6.10
- Resistance Level
- AMLX $12.25
- HFRO $6.53
- Average True Range (ATR)
- AMLX 0.54
- HFRO 0.07
- MACD
- AMLX 0.19
- HFRO -0.33
- Stochastic Oscillator
- AMLX 98.04
- HFRO 99.85
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.